Optimizing Blood Utilization: Strategies for Improving Hemostatic Practices

Publication

Faculty

Robert MacLaren, PharmD, FCCM, FCCP
Associate Professor
University of Colorado
Skaggs School of Pharmacy and Pharmaceutical Sciences
Critical Care Pharmacy Specialist
University of Colorado Hospital
Denver, Colorado

Michael Gabay, PharmD, JD, BCPS
Clinical Associate Professor
Director – Drug Information Group/Prior Authorization Services
University of Illinois at Chicago
College of Pharmacy
Chicago, Illinois

Intended Learners

This activity is designed for health-system pharmacists.

Learning Objectives

After completing this activity, participants should be able to:

Discuss the clinical and economic impact of surgical bleeding and transfusions
Outline the clinical profiles of available topical and systemic hemostatic agents
Promote strategies aligned with the Joint Commission's Patient Blood Management Performance Measures Project, including optimizing hemostatic practices
Develop pharmacy oversight of the institutional use of hemostatic agents

Activity Overview

To be eligible for documentation of credit, participants must read all monograph content, complete the 10-question post-test with a score of 70% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.

Release date: December 22, 2011
Expiration date: December 22, 2012
Estimated time to complete: 1 hour, 45 minutes

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.

There is no fee associated with this activity.

For questions regarding this educational activity, please call 609-371-1137.

Hardware/Software Requirements

All educational activities are accessible via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome or Safari. Windows Media Player or compatible alternative, sound card, and speakers are required for streamed audio. The latest version of the Adobe Flash Player is suggested (please download here) for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

Accreditation

In support of improving patient care, North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

CPE

This activity is approved for 1.75 contact hours (0.175 CEUs) of continuing pharmacy education (276-000-11-073-H01-P).

Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity accredited by NACCME may contact Assistant Director, Accreditation Services, NACCME, in writing at 300 Rike Drive, Suite A, Millstone Township, NJ 08535, or by e-mail at info@naccme.com. The Assistant Director, Accreditation Services will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Senior Director, Accreditation Services, NACCME, may be made for a second level of review.

Independent Clinical Reviewer: Wendy Cantrell, PharmD, BCPS, BCNSP, CACP, Cardiology/Anticoagulation Specialist, University Medical Center of Southern Nevada, Assistant Professor, University of Southern Nevada College of Pharmacy, Las Vegas, Nevada

Medical writer Deborah J. Neveleff contributed to the writing of this newsletter.

Planning Committee

The planning committee comprises Wendy Cantrell, PharmD, BCPS, BCNSP, CACP; Michael Gabay, PharmD, JD, BCPS; Robert MacLaren, PharmD, FCCM, FCCP; Deborah J. Neveleff; Kristin Ciszeski, Mary Johnson, Michael Kearney, Nick Lombardi, Randy Robbin, and John Savage, NACCME.

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

Dr. Gabay: Board Member—Bristol-Myers Squibb
Dr. MacLaren: Grant/research support—Hospira; Scientific Advisor—GlaxoSmithKline
Dr. Cantrell and Ms. Neveleff disclosed no relevant financial relationships with any commercial interests.

Ms. Ciszeski, Ms. Johnson, Mr. Kearney, Mr. Robbin, and Mr. Savage have disclosed no relevant financial relationships with any commercial interests.

Mr. Lombardi: Stock shareholder—Inspire Pharmaceuticals, Inc, Vertex Pharmaceuticals, Inc, ViroPharma, Inc

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty has disclosed that the following off-label/unapproved drugs and/or devices will be discussed: Factor viia for use in hemorrhage therapy/prevention.

This continuing medical education activity includes device brand names for participant clarity purposes only, due to the presence of different branded versions of the same device. No product promotion or recommendation should be inferred.

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2011 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.

Grant Support

Supported by an educational grant from ZymoGenetics, Inc.